MARKET

VOR

VOR

Vor Biopharma Inc.
NASDAQ
14.52
+0.95
+6.96%
Opening 10:11 03/27 EDT
OPEN
13.65
PREV CLOSE
13.57
HIGH
14.98
LOW
13.65
VOLUME
406.20K
TURNOVER
--
52 WEEK HIGH
65.80
52 WEEK LOW
2.622
MARKET CAP
602.66M
P/E (TTM)
-0.0375
1D
5D
1M
3M
1Y
5Y
1D
VOR BIOPHARMA SHARES RISE 1.5% AFTER $75 MILLION PRIVATE PLACEMENT
Reuters · 4h ago
BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Phathom, Argan
Reuters · 4h ago
Vor Biopharma Announces $75 Million Private Placement Financing
TipRanks · 4h ago
BUZZ-Vor Bio climbs after announcing $75 mln private placement 
Reuters · 5h ago
Vor Bio to sell 5.338M shares at $14.05 in private placement
TipRanks · 5h ago
VOR BIOPHARMA SHARES CLIMB 6.4% PREMARKET AFTER $75 MILLION PRIVATE PLACEMENT
Reuters · 5h ago
Vor Bio Commences ~$75M Offering Of 5.338M Common Shares At $14.05/Share
Benzinga · 5h ago
*Vor Bio Anticipates Gross Proceeds at About $75M >VOR
Dow Jones · 5h ago
More
About VOR
Vor Biopharma Inc. is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a dual-target fusion protein, through Phase III clinical development and commercialization to address serious autoantibody-driven conditions worldwide. Telitacicept is an investigational recombinant fusion protein designed to treat autoimmune diseases by selectively inhibiting BLyS (BAFF) and APRIL - two cytokines essential to B cell and plasma cell survival. This dual-target mechanism reduces autoreactive B cells and autoantibody production, key drivers of autoimmune pathology. Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase III clinical trial in gMG is underway across the United States, Europe, and South America to support potential approval in the United States and Europe.

Webull offers Vor Biopharma Inc stock information, including NASDAQ: VOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VOR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VOR stock methods without spending real money on the virtual paper trading platform.